Molecular Tumor Board - Metastatic melanoma with CDKN2A and PD-L1
2 Views
administrator
07/03/23
Dr. Paul Walker conducts a virtual Molecular Tumor Board. The subject is a Molecular Tumor Board - Metastatic melanoma with a normal LDH. Remarkable markers include CDKN2A and PD-L1.
Dr. Walker discusses the treatment and supporting studies for his assessment.
-
Category
Show more
Facebook Comments
No comments found